UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	October 17, 2018

Accession Number:	0001171843-18-006965
Submission Type:	POS AM
CIK: 0001444192 Company Name: Acasti Pharma Inc. File Number: 333-220755